You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma

Article info

Article menu

Download PDFPDF

Research Article
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Free

Authors

  • Danielle M Lussier Molecular and Cellular Biology Graduate ProgramArizona State University 85281 Tempe AZ USA Center for Infectious Diseases and Vaccinology, BioDesign InstituteArizona State University 727 E. Tyler St. 85287 Tempe AZ USA PubMed articlesGoogle scholar articles
  • John L Johnson Center for Infectious Diseases and Vaccinology, BioDesign InstituteArizona State University 727 E. Tyler St. 85287 Tempe AZ USA PubMed articlesGoogle scholar articles
  • Pooja Hingorani Center for Cancer and Blood DisordersPhoenix Children’s Hospital 85016 Phoenix AZ USA PubMed articlesGoogle scholar articles
  • Joseph N Blattman Molecular and Cellular Biology Graduate ProgramArizona State University 85281 Tempe AZ USA Center for Infectious Diseases and Vaccinology, BioDesign InstituteArizona State University 727 E. Tyler St. 85287 Tempe AZ USA PubMed articlesGoogle scholar articles

Citation

Lussier DM, Johnson JL, Hingorani P, et al
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Journal for ImmunoTherapy of Cancer 2015;3:21. doi: 10.1186/s40425-015-0067-z
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2015